The construction of in vivo models of breast cancer metastasis to the bone further confirmed the inhibition of bone metastasis as a result of CXCR4 interference and the involvement of CXCR4/PI3K/AKT/MMP-9 signaling in bone metastasis. The gene discussed is CXCR4; the disease is breast carcinoma.